Study of @neWorld: A Virtual Community for Children With Cancer

NCT ID: NCT00070421

Last Updated: 2013-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Study Classification

INTERVENTIONAL

Study Start Date

2003-04-30

Study Completion Date

2005-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Using an Internet Web site that enables children with cancer to interact online with classmates, participate in classroom activities, get easy-to-read medical information, and chat with family members, medical staff, and other children with cancer may help children cope with isolation, fear, and decreased self-esteem.

PURPOSE: This phase I/II trial is studying the effectiveness of an Internet Web site in providing social support and education to children who are undergoing treatment for cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* Develop an Internet-based application that allows pediatric patients with cancer to enter a virtual community with the following capabilities:

* Interact with classmates and participate in classroom activities via e-mail, chat groups, online field trips, art studio, music room, and game room
* Identify and interact with a community of peers with similar medical conditions
* Access a dictionary to get medical information in understandable terms
* Interact with the medical community online
* Interact with family members online
* Determine the acceptability of this program among groups of these patients and their classmates, teachers, family members, and healthcare providers using focus groups.
* Determine the effect of this program on self-esteem, coping behaviors, perceived social support, cancer-relevant medical knowledge, and feelings of control over health destiny in these patients.
* Determine the effect of this program on the performance of these patients in school.
* Determine the effect of this program in alleviating psychological distress in these patients.

OUTLINE: This is a multicenter study.

* Phase I: Students, family members, teachers, and health providers participate in focus groups to provide system design and implementation input and to assess overall acceptability of a prototype Internet-based application for pediatric cancer patients.
* Phase II: Patients are assigned to 1 of 2 groups, based on participating center.

* Group 1: Patients have access to and utilize the Internet-based application @neWorld.
* Group 2: Patients do not have access to or utilize @neWorld. In both groups, patients complete questionnaires measuring psychological distress, quality of life, self-esteem, coping behaviors, perceived academic and social competence, perceived social support, cancer-relevant medical knowledge, feelings of control over health destiny, utilization of psychological services, and performance in school at baseline and 3 and 6 months.

PROJECTED ACCRUAL: A total of 94 patients (44 for group 1 and 50 for group 2) will be accrued for this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leukemia Lymphoma Psychosocial Effects of Cancer and Its Treatment Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

complementary or alternative medicine procedure

Intervention Type PROCEDURE

management of therapy complications

Intervention Type PROCEDURE

psychosocial assessment and care

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Diagnosis of cancer
* Currently receiving treatment for cancer

PATIENT CHARACTERISTICS:

Age

* 10 to 15

Performance status

* Active

Life expectancy

* Not specified

Hematopoietic

* Not specified

Hepatic

* Not specified

Renal

* Not specified

Other

* Able to read and speak English

PRIOR CONCURRENT THERAPY:

Biologic therapy

* Not specified

Chemotherapy

* Not specified

Endocrine therapy

* Not specified

Radiotherapy

* Not specified

Surgery

* Not specified
Minimum Eligible Age

10 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Leap of Faith Technologies

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara Rapchak

Role: STUDY_CHAIR

Leap of Faith Technologies

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Leap of Faith Technologies, Incorporated

Crystal Lake, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDR0000334398

Identifier Type: REGISTRY

Identifier Source: secondary_id

WCCC-2000-194

Identifier Type: -

Identifier Source: secondary_id

LFT-NEWORLD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.